GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Hamps Bio Ltd

Hamps Bio completes acquisition of HSDL Innovative for INR 2.04 Crore

M&A ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 25 Mar 2026, 04:42 PM IST  ·  BSE ID: 431233f3-9b9f-4757-a27e-eed9c19ea8c5
View Original BSE Filing (PDF)
💡
In Simple Terms
Hamps Bio just finished buying a private company called HSDL Innovative for INR 2.04 Crore in cash and now fully owns it.
🤖 AI Summary
  • Acquisition of 100% equity of HSDL Innovative completed for INR 2,04,00,000 in cash
  • Target company became wholly owned subsidiary effective March 25, 2026
  • Earlier announcement made February 14, 2026; detailed Schedule III disclosures already filed
  • Target company CIN: U15136GJ2017PTC095843, registered in Gujarat
🔢 Key Numbers - exact figures from BSE filing, not rounded
Acquisition consideration
INR 2,04,00,000
Equity stake acquired
100% paid-up equity capital
Acquisition effective date
March 25, 2026
🏢 How This Affects the Company
📈
Business Impact
HSDL Innovative becomes a wholly owned subsidiary, expanding Hamps Bio's business portfolio and revenue streams. The subsidiary's existing operations are now consolidated under Hamps Bio's control.
💰
Financial Impact
Acquisition outlay of INR 2,04,00,000 has reduced cash on Hamps Bio's balance sheet. HSDL Innovative's assets, liabilities, and earnings are now consolidated into Hamps Bio's financial statements from March 25, 2026.
⚙️
Operational Impact
HSDL Innovative's management, employees, and operations are now under Hamps Bio's direct operational control. Integration of systems, processes, and governance frameworks is underway.
⚠️
Risk Impact
Integration risk exists in aligning two separate entity cultures and systems. Acquisition success depends on retaining HSDL Innovative's existing client base and operational continuity.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Shareholders should monitor Q4 FY26 and FY27 results for consolidated financials and synergy realization metrics.
👤
Who Is Affected
All equity shareholders of Hamps Bio. Balance sheet will include HSDL Innovative's assets and liabilities from March 25, 2026. EPS impact depends on target company's profitability and acquisition ROI.
🔍
Management Signal
Management has deployed cash capital to expand business portfolio via inorganic growth. This signals growth ambitions beyond organic expansion.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q4 FY26 results filing — verify consolidated financials include HSDL Innovative from March 25 onwards
FY27 results and management commentary — assess synergy realization and acquired company's revenue contribution
Board meetings — watch for updates on integration progress and operational metrics of subsidiary
MEDIUM RISK Acquisition integration risk and limited disclosure on target company's financials, profitability, and revenue contribution to parent.
💡 Investor Takeaway
Hamps Bio has completed acquisition of HSDL Innovative for INR 2,04,00,000 cash, now a wholly owned subsidiary effective March 25, 2026. Full regulatory disclosures under Schedule III already filed February 14. Integration outcomes and consolidated profitability impact remain to be demonstrated in future results.
⚖️ Strengths & Concerns

✅ Positives

  • Acquisition completed in cash with no debt financing, preserving balance sheet flexibility and avoiding interest burden.
  • Target company incorporated 2017 with established operations, not a startup venture, reducing operational execution risk.

⚠️ Concerns

  • No disclosed rationale for acquisition, synergies, or expected profitability impact limits investor visibility into value creation thesis.
  • Limited public disclosure on HSDL Innovative's financials, client base, or revenue contribution to consolidated entity.
You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.